Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States

Abstract

GPP and PPP patients have significant economic burden due to higher direct medical and pharmacy costs. Further investigation is needed to better understand the drivers of economic burden in patients with GPP and PPP, and how HCRU and costs are impacted by disease severity.